A
Aditxt, Inc. (ADTX)
NCM – Real Time Price. Currency in USD
0.81
-0.07 (-7.95%)
At close: Mar 27, 2026, 4:00 PM EDT
0.82
+0.01 (1.49%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
0.81
-0.07 (-7.95%)
At close: Mar 27, 2026, 4:00 PM EDT
0.82
+0.01 (1.49%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
| Name | Position |
|---|---|
| Dr. Dolly B. Tyan D(ABHI), Ph.D. | Senior Vice President of Clinical Development Transplantation |
| Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D. | Co-Founder, Chief Innovation Officer, Secretary & Director |
| Mr. Amro A. Albanna | Co-Founder, Chairman, CEO & President |
| Mr. Christopher J. Porcelli | General Counsel |
| Mr. Ge Chen M.D., M.S. | Senior Vice President of Preclinical Research & Discovery |
| Mr. Thomas J. Farley CPA | Chief Financial Officer |
| Ms. Corinne D. Pankovcin CPA, M.B.A. | Chief Mergers & Acquisitions Officer |
| Date | Type | Document |
|---|---|---|
| 2026-03-13 | 8-K | ea0279443-8k_aditxt.htm |
| 2026-03-05 | 8-K | ea0280063-8k_aditxt.htm |
| 2026-01-30 | 8-K | ea0274881-8k_aditxt.htm |
| 2026-01-28 | 8-K | ea0274343-8k_aditxt.htm |
| 2025-12-16 | DEF 14A | ea0269766-def14a_aditxt.htm |
| 2025-12-05 | 8-K | ea0268358-8k_aditxt.htm |
| 2025-11-18 | DEFA14A | ea0266125-8kdef14a_aditxt.htm |
| 2025-11-17 | NT 10-Q | ea0265950-nt10q_aditxt.htm |
| 2025-11-14 | PRE 14A | ea0265449-pre14a_aditxt.htm |
| 2025-10-31 | 8-K | ea0263285-8k_aditxt.htm |
| Ms. Jennifer Lee | Director of Human Resources |
| Ms. Rowena Albanna | Chief Operating Officer |